KELLY MONTGOMERY: Open Payments
NPI 1609466770 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 34 payments from 13 companies in 2025. Trend: 2023 $589 · 2024 $684 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $96 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Alkermes, Inc. | 4 | $75 |
| ABBVIE INC. | 3 | $65 |
| Lundbeck LLC | 2 | $34 |
| ARGENX US, INC. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
Products named: REXULTI, CAPLYTA, Kcentra, Auvelity, LYBALVI, VRAYLAR, Privigen, VYVGART HYTRULO.
Industry payments across OH — which companies pay providers there.
